Select Publications

Conference Abstracts

Behary J; Raposo A; Zheng H; Amorim N; Gong L; Mcgovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Defining the temporal evolution of the gut microbiome and associated intrahepatic immune response in the Mdr2-/- model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Behary J; Amorim N; Jiang X; Raposo A; Gong L; Mcgovern E; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rees V; Behary J; Stephens C; Jebeili H; Szczesniak M; Zekry A; Freiman J, 2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zekry A; Rimassa L; Kelley R; Meyer T; Ryoo B; Merle P; Park J; Blanc J; Lim H; Tran A; Borgman-Hagey A; Clary D; Wang E; Cheng A; El-Khoueiry A; Abou-Alfa G, 2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kharbat M; Rolls S; Pavendranathan G; Choo L; Zekry A, 2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page